MAPT and Cognitive impairment: These results are consistent with the findings in the Harvard Aging Brain Study (HABS) which found the DCTclock can detect cognitive impairment with high accuracy and correlates with amyloid and tau burden in pre-symptomatic individuals (Rentz et al., 2021).